171 related articles for article (PubMed ID: 16878437)
1. Rescue treatment for cyclosporine-associated hemolytic-uremic syndrome with intravenous immunoglobulin.
Wen YK; Chen ML
Clin Nephrol; 2006 Jul; 66(1):58-62. PubMed ID: 16878437
[TBL] [Abstract][Full Text] [Related]
2. Hemolytic-uremic syndrome in association with both cyclosporine and tacrolimus.
Abraham KA; Little MA; Dorman AM; Walshe JJ
Transpl Int; 2000; 13(6):443-7. PubMed ID: 11140243
[TBL] [Abstract][Full Text] [Related]
3. Successful use of cyclosporine in a lung transplant recipient with tacrolimus-associated hemolytic uremic syndrome.
Myers JN; Shabshab SF; Burton NA; Nathan SD
J Heart Lung Transplant; 1999 Oct; 18(10):1024-6. PubMed ID: 10561115
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors and early resumption of cyclosporin A in renal allograft recipients with thrombotic microangiopathy and hemolytic uremic syndrome.
Wiener Y; Nakhleh RE; Lee MW; Escobar FS; Venkat KK; Kupin WL; Mozes MF
Clin Transplant; 1997 Jun; 11(3):157-62. PubMed ID: 9193835
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus (FK506) associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in lung transplant salvage with a plasmapheresis and cyclosporin.
Boctor FN
Egypt J Immunol; 2006; 13(2):95-9. PubMed ID: 18689275
[TBL] [Abstract][Full Text] [Related]
6. Transplant-associated thrombotic microangiopathy: the role of IgG administration as initial therapy.
Hochstetler LA; Flanigan MJ; Lager DJ
Am J Kidney Dis; 1994 Mar; 23(3):444-50. PubMed ID: 8128949
[TBL] [Abstract][Full Text] [Related]
7. [De novo hemolytic uremic syndrome in a kidney-pancreas recipient in the postoperative period].
Gutiérrez de la Fuente C; Sola E; Alférez MJ; Navarro A; Cabello M; Burgos D; González Molina M
Nefrologia; 2004; 24 Suppl 3():3-6. PubMed ID: 15219059
[TBL] [Abstract][Full Text] [Related]
8. A case of late onset cyclosporine-induced hemolytic uremic syndrome resulting in renal graft loss.
Katafuchi R; Saito S; Ikeda K; Hirano T; Yanase T; Nakashima K; Fujimi S
Clin Transplant; 1999; 13 Suppl 1():54-8. PubMed ID: 10751058
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporine-induced hemolytic uremic syndrome and hemorrhagic colitis following renal transplantation.
Lapointe M; Baillie GM; Bhaskar SS; Richardson MS; Self SE; Baliga PK; Rajagopalan PR
Clin Transplant; 1999 Dec; 13(6):526-30. PubMed ID: 10617244
[TBL] [Abstract][Full Text] [Related]
10. Posttransplant hemolytic uremic syndrome in adult retransplanted kidney graft recipients: advantage of FK506 therapy?
Franz M; Regele H; Schmaldienst S; Stummvoll HK; Hörl WH; Pohanka E
Transplantation; 1998 Nov; 66(9):1258-62. PubMed ID: 9825827
[TBL] [Abstract][Full Text] [Related]
11. Post-renal transplant hemolytic uremic syndrome following combination therapy with tacrolimus and everolimus.
Pratap B; Abraham G; Srinivas CN; Bhaskar S
Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):609-12. PubMed ID: 17951952
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities.
Furlong T; Storb R; Anasetti C; Appelbaum FR; Deeg HJ; Doney K; Martin P; Sullivan K; Witherspoon R; Nash RA
Bone Marrow Transplant; 2000 Nov; 26(9):985-91. PubMed ID: 11100278
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine-associated thrombotic microangiopathy/hemolytic uremic syndrome following kidney and kidney-pancreas transplantation.
Young BA; Marsh CL; Alpers CE; Davis CL
Am J Kidney Dis; 1996 Oct; 28(4):561-71. PubMed ID: 8840947
[TBL] [Abstract][Full Text] [Related]
14. Tacrolimus-associated hemolytic uremic syndrome: a case analysis.
Lin CC; King KL; Chao YW; Yang AH; Chang CF; Yang WC
J Nephrol; 2003; 16(4):580-5. PubMed ID: 14696762
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine A-related hemolytic uremic syndrome after living renal transplantation-case report.
Wołyniec W; Debska-Slizień A; Chamienia A; Ignacy Pirski M; Łysiak-Szydłowska W; Sledziński Z; Rutkowski B
Transplant Proc; 2002 Mar; 34(2):569-71. PubMed ID: 12009627
[No Abstract] [Full Text] [Related]
16. Cyclosporin conversion to CellCept in a cadaveric renal allograft recipient with hemolytic uremic syndrome.
Said T; al-Mousawi M; Samhan M; Lao M
Transplant Proc; 1999 Dec; 31(8):3295-7. PubMed ID: 10616482
[No Abstract] [Full Text] [Related]
17. Hemolytic uremic syndrome following Campath-1H induction.
Bonatti H; Brandacher G; Boesmueller C; Cont M; Hengster P; Rosenkranz AR; Krugmann J; Margreiter R
Transpl Int; 2007 Apr; 20(4):386-9. PubMed ID: 17326780
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine-induced hemolytic uremic syndrome in a heart transplant recipient.
Galli FC; Damon LE; Tomlanovich SJ; Keith F; Chatterjee K; DeMarco T
J Heart Lung Transplant; 1993; 12(3):440-4. PubMed ID: 8329415
[TBL] [Abstract][Full Text] [Related]
19. Hemolytic and uremic syndrome after heart transplantation.
Mercadal L; Petitclerc T; Assogba U; Beaufils H; Deray G
Am J Nephrol; 2000; 20(5):418-20. PubMed ID: 11093002
[TBL] [Abstract][Full Text] [Related]
20. Conversion of renal transplant recipients from cyclosporin (neoral) to tacrolimus (prograf) for haemolytic uraemic syndrome.
Morris-Stiff G; Talbot D; Balaji V; Baboolal K; Callanan K; Hails J; Moore R; Manas D; Lord R; Jurewicz WA
Transpl Int; 1998; 11 Suppl 1():S98-9. PubMed ID: 9664954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
